IL1A and neoplasm: While the abundance and spatial localization of iCAFs and myCAFs are likely regulated by several signaling pathways (e.g. TGF-β), our in vivo findings suggest that the acquisition of p63 expression in the tumor leads to a potent increase in IL-1 secretion to drive iCAF enrichment in the surrounding microenvironment.